Med· Ottaiano·收录于· 6 天前
When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma
When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma
来源:Med · doi.org